swollen lymph node; swollen arm; strong pain in the shoulder; strong sporadic headaches; fever; pain in the arm; burning skin all over the body; exhaustion; this is a spontaneous report received from a contactable reporter (consumer) from the regulatory agency (ra). regulatory number: gb-mhra-vac-202202201048552880-dugx9 (ra). other case identifier(s): gb-mhra-adr 26641879 (ra). a female patient received bnt162b2 (comirnaty), administration date 09feb2022 (batch/lot number: unknown) as dose number unknown, single for covid-19 immunisation. the patient had no relevant medical history (no medicines were taken, no medical condition). the patient's concomitant medications were not reported. the following information was reported: fatigue (medically significant) with onset 09feb2022, outcome "recovering", described as "exhaustion"; headache (medically significant) with onset 10feb2022, outcome "recovering", described as "strong sporadic headaches"; pyrexia (medically significant) with onset 10feb2022, outcome "recovering", described as "fever"; pain in extremity (medically significant) with onset 10feb2022, outcome "recovering", described as "pain in the arm"; skin burning sensation (medically significant) with onset 10feb2022, outcome "recovering", described as "burning skin all over the body"; lymphadenopathy (medically significant) with onset 11feb2022, outcome "recovering", described as "swollen lymph node"; peripheral swelling (medically significant) with onset 11feb2022, outcome "recovering", described as "swollen arm"; arthralgia (medically significant) with onset 11feb2022, outcome "recovering", described as "strong pain in the shoulder". the clinical course was reported as follows: the first day after the vaccine, the patient experienced exhaustion, sporadic strong headaches, burning skin, fever, pain in the arm and patient was not able to do the daily activities due to events. the second day of the vaccine, the patient experienced swollen arm, swollen lymph node, strong pain in the shoulder and pain in the arm. the swollen lymph node is still recovering 10 days after the vaccine. no follow-up attempts are possible; information about lot/batch number cannot be obtained. no further information is expected